We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksATMA.L Regulatory News (ATMA)

  • There is currently no data for ATMA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement re Conversion Price Adjustment of Bonds

6 Sep 2017 17:50

RNS Number : 0395Q
ATLAS Mara Limited
06 September 2017
 

NOT FOR DISTRIBUTION OR TRANSMISSION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES

6 September 2017

ATLAS MARA LIMITED

Notice of adjustment of the Conversion Price of U.S.$63,400,000 and U.S.$17,400,000 8.00 per cent Secured Convertible Bonds due 2020 (Rule 144A ISIN: XS1298407229; Regulation S ISIN: XS1297883214) (together, the "Bonds")

Please be advised that further to its announcement on 21 June 2017 in relation to the strategic financing agreement reached with Fairfax Africa Holdings Corporation and the issuance of $200 million of new capital comprising a $100 million equity offering of new Ordinary Shares (the "Equity Offering") and a $100 million mandatory convertible bond issuance (the "Mandatory Convertible Bonds"), and further to its announcement on 17 July 2017 regarding the adjustment of the Conversion Price per Ordinary Share in respect of the Bonds to reflect the completion of the issuance of the Mandatory Convertible Bonds, Atlas Mara Limited has, in accordance with the terms and conditions of the Bonds (the "Terms and Conditions"), given notice to the Trustee and the Bondholders that the Conversion Price per Ordinary Share in respect of the Bonds has been adjusted in accordance with the Terms and Conditions in order to reflect the completion of the issuance of Ordinary Shares pursuant to the Equity Offering (the "Adjustment"). The Adjustment becomes effective on 31 August 2017 (the "Effective Date"). Prior to the Effective Date, the Conversion Price per Ordinary Share was U.S.$10.51. The adjusted Conversion Price per Ordinary Share, computed in accordance with Condition 7(b)(vi) of the Terms and Conditions, is U.S.$10.14.

Capitalised terms not otherwise defined in this announcement shall have the meanings given to them in the Terms and Conditions.

For further information, please contact: 

Investors

Kojo Dufu, +1 212 883 4330

Media

Teneo Blue Rubicon, +44 (20) 7260 2700

Anthony Silverman

 

 

 

DISCLAIMER - INTENDED ADDRESSEES

This announcement does not constitute an offer of any securities for sale.

The Bonds and any ordinary shares which may be delivered upon conversion of the Bonds have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act").

The distribution of this announcement in certain jurisdictions may be restricted by law. Persons into whose possession this announcement comes are required to inform themselves about and to observe any such restrictions.

This announcement has been prepared solely for information purposes and is not an offer (or a solicitation of an offer) to buy or sell any securities in any jurisdiction.

END

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRDMGGLVVNGNZM
Date   Source Headline
23rd Nov 20214:35 pmRNSPrice Monitoring Extension
10th Nov 20214:41 pmRNSSecond Price Monitoring Extn
10th Nov 20214:35 pmRNSPrice Monitoring Extension
2nd Nov 20214:41 pmRNSSecond Price Monitoring Extn
2nd Nov 20214:35 pmRNSPrice Monitoring Extension
27th Oct 20214:40 pmRNSSecond Price Monitoring Extn
27th Oct 20214:35 pmRNSPrice Monitoring Extension
25th Oct 20215:50 pmRNSStrategic Update and Voluntary Delisting
11th Oct 20215:51 pmRNSNotice of Results of Meeting of Noteholders
8th Oct 20214:41 pmRNSSecond Price Monitoring Extn
8th Oct 20214:36 pmRNSPrice Monitoring Extension
16th Sep 20214:40 pmRNSSecond Price Monitoring Extn
16th Sep 20214:35 pmRNSPrice Monitoring Extension
1st Sep 20218:51 amRNS2020 Annual Financial Statements
31st Aug 20216:28 pmRNS2020 Year-End Results
25th Aug 20212:49 pmRNSBPR Sale Completion to KCB & Notice to Investors
22nd Jul 202112:35 pmRNSSuccessful Dismissal of TLG Petition
14th Jul 20215:13 pmRNSAtlas Mara Announces Successful Restructuring
1st Jul 20217:30 amRNSSuspension - Atlas Mara Limited
1st Jul 20217:00 amRNSHalt in Trading & Upcoming Reporting
29th Jun 20211:59 pmRNSExtension of Accounting Reference Date
19th May 20217:00 amRNSRestructuring Discussions and Strategic Review
5th May 20217:12 amRNSStrategic Review and Restructuring Discussions
19th Apr 20217:00 amRNSStrategic Transaction with Access Bank Plc
12th Apr 202111:17 amRNSUpdate on Standstill and Statement re Norsad
1st Apr 20217:02 amRNSUpdate on Standstill and In Principle Agreement
22nd Mar 20214:41 pmRNSSecond Price Monitoring Extn
22nd Mar 20214:36 pmRNSPrice Monitoring Extension
10th Mar 20217:00 amRNSNotice of Results of Meeting of Noteholders
5th Mar 20216:29 pmRNSVoting Rights & Director/PDMR Shareholding Update
26th Feb 20214:40 pmRNSSecond Price Monitoring Extn
26th Feb 20214:35 pmRNSPrice Monitoring Extension
17th Feb 20218:34 amRNSUpdate on Standstill and Statement regarding TLG
25th Jan 20214:40 pmRNSSecond Price Monitoring Extn
25th Jan 20214:35 pmRNSPrice Monitoring Extension
25th Jan 20217:30 amRNSAtlas Mara Addresses Market Rumours
19th Jan 20214:41 pmRNSSecond Price Monitoring Extn
19th Jan 20214:35 pmRNSPrice Monitoring Extension
5th Jan 20216:16 pmRNSNotification of Major Interest in Shares
4th Jan 20215:46 pmRNSRepurchase of Shares and Total Voting Rights
31st Dec 202012:40 pmRNSSecond Price Monitoring Extn
31st Dec 202012:35 pmRNSPrice Monitoring Extension
30th Dec 20205:30 pmRNSReissued Notice to Bondholders
29th Dec 20209:00 amRNSNotice to Bondholders
29th Dec 20207:03 amRNSNew Financing and Standstill Agreement
14th Dec 20206:20 pmRNSNotification of Major Interest in Shares
14th Dec 20206:16 pmRNSNotification of Major Interest in Shares
26th Nov 20207:00 amRNSStrategic Transaction with KCB Group Plc
24th Nov 20204:41 pmRNSSecond Price Monitoring Extn
24th Nov 20204:36 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.